𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel Activators of the Tumour Suppressor p53

✍ Scribed by Nils Sunder-Plassmann; Athanassios Giannis

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
117 KB
Volume
5
Category
Article
ISSN
1439-4227

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Mutations of p53 tumor-suppressor gene i
Mutations of p53 tumor-suppressor gene in angiosarcoma
✍ Norifumi Naka; Yasuhiko Tomita; Hirofumi Nakanishi; Nobuhito Araki; Tadashi Hong πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 50 KB πŸ‘ 3 views

Transgenic mice deficient for the p53 gene were reported to frequently develop angiosarcoma (AS), suggesting that alterations in the gene are associated with tumorigenesis of AS. However, little is known about genetic changes, including p53 gene alterations, in human AS because of its rarity. We ana

Pilot screening programme for small mole
Pilot screening programme for small molecule activators of p53
✍ Rachel G. Berkson; Jonathan J. Hollick; Nicholas J. Westwood; Julie A. Woods; Da πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 328 KB

## Abstract Activation of the p53 tumour suppressor is predicted to have therapeutically beneficial effects. Many current anti‐cancer therapies activate the p53 response __via__ DNA damage. Non‐genotoxic activation of the p53 pathway would open the way to long‐term and possibly prophylactic treatme